CYP2B6 and OPRM1 gene variations predict methadone-related deaths

被引：43

作者：

Bunten, Hannah ^{[1
]}

Liang, Wei-Jun ^{[1
]}

Pounder, Derrick ^{[2
]}

Seneviratne, Collin ^{[2
]}

Osselton, Michael David ^{[1
]}

机构：

[1] Bournemouth Univ, Ctr Forens Sci, Poole BH12 5BB, Dorset, England

[2] Univ Dundee, Ctr Forens & Legal Med, Dundee DD1 4HN, Scotland

来源：

ADDICTION BIOLOGY | 2011年 / 16卷 / 01期

关键词：

CYP2B6; fatalities; metabolism; methadone; OPRM1; pharmacogenomics; PLASMA-LEVELS; PHARMACOKINETICS; POLYMORPHISMS; GENOTYPES; CHANNEL;

D O I：

10.1111/j.1369-1600.2010.00274.x

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The largest proportion of methadone-associated deaths occurs during the drug induction phase. We analysed methadone-related fatalities for gene variations linked with methadone action. A significant association between high methadone concentrations and the CYP2B6*6 allele characteristic of the slow metabolizer phenotype was identified. We suggest that the risk of methadone fatality may be predetermined in part by the CYP2B6*6 allele. A significant correlation was also observed between post-mortem benzodiazepine concentrations and the OPRM1 A118G allele GA in methadone-related fatalities. Screening for these susceptibility variations prior to methadone prescription could assist in reducing the potential for serious adverse effects.

引用

页码：142 / 144

页数：3

共 17 条

[1] Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity:: Possible implications for opiate addiction [J].

Bond, C ;

LaForge, KS ;

Tian, MT ;

Melia, D ;

Zhang, SW ;

Borg, L ;

Gong, JH ;

Schluger, J ;

Strong, JA ;

Leal, SM ;

Tischfield, JA ;

Kreek, MJ ;

Yu, L .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9608-9613

[2] Fatal methadone toxicity: signs and circumstances, and the role of benzodiazepines [J].

Caplehorn, John R. M. ;

Drummer, Olaf H. .

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2002, 26 (04) :358-362

[3] Mechanisms of respiratory insufficiency induced by methadone overdose in rats [J].

Chevillard, Lucie ;

Megarbane, Bruno ;

Baud, Frederic J. ;

Risede, Patricia ;

Decleves, Xavier ;

Mager, Donald ;

Milan, Nathalie ;

Ricordel, Ivan .

ADDICTION BIOLOGY, 2010, 15 (01) :62-80

[4] Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment [J].

Crettol, S ;

Déglon, JJ ;

Besson, J ;

Croquette-Krokkar, M ;

Gothuey, I ;

Hämmig, R ;

Monnat, M ;

Hüttemann, H ;

Baumann, P ;

Eap, CB .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (06) :593-604

[5] ABCB1 and cytochrome P450 genotypes and phenotypes:: Influence on methadone plasma levels and response to treatment [J].

Crettol, Severine ;

Deglon, Jean-Jacques ;

Besson, Jacques ;

Croquette-Krokar, Marina ;

Haemmig, Robert ;

Gothuey, Isabelle ;

Monnat, Martine ;

Eap, Chin B. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (06) :668-681

[6] Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers [J].

Eap, C. B. ;

Crettol, S. ;

Rougier, J-S ;

Schlaepfer, J. ;

Grilo, L. Sintra ;

Deglon, J-J ;

Besson, J. ;

Croquette-Krokar, M. ;

Carrupt, P-A ;

Abriel, H. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (05) :719-728

[7] Interindividual variability of the clinical pharmacokinetics of methadone - Implications for the treatment of opioid dependence [J].

Eap, CB ;

Buclin, T ;

Baumann, P .

CLINICAL PHARMACOKINETICS, 2002, 41 (14) :1153-1193

[8] Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19 [J].

Gerber, JG ;

Rhodes, RJ ;

Gal, J .

CHIRALITY, 2004, 16 (01) :36-44

[9] Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6 [J].

Kirchheiner, J ;

Klein, C ;

Meineke, I ;

Sasse, J ;

Zanger, UM ;

Mürdter, TE ;

Roots, I ;

Brockmöller, J .

PHARMACOGENETICS, 2003, 13 (10) :619-626

[10] Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver [J].

Lang, T ;

Klein, K ;

Fischer, J ;

Nüssler, AK ;

Neuhaus, P ;

Hofmann, U ;

Eichelbaum, M ;

Schwab, M ;

Zanger, UM .

PHARMACOGENETICS, 2001, 11 (05) :399-415

← 1 2 →